Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07514663 · ClinicalTrials.gov registry record · NA
Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
A NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Recruiting
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT07514663: Recruiting NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
NCT07514663 is a NA study that is actively recruiting participants, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07514663, a NA study, is actively recruiting participants, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess the effects of corn and avocado oils as part of controlled feeding diets on the cardiometabolic risk factor profile in men and women with mild-to-moderately elevated levels of non-high-density lipoprotein cholesterol (non-HDL-C). Participants will be asked to consume the controlled feeding diet for two separate 21 day conditions, and will consume their regular diet for a 21 day washout period between the two conditions. Additionally, participants will be asked to come into the clinic on 7 different occasions, including one screening visit (visit 1, -7 days), one baseline visit (visit 2, day 0), two visits during each 21-d diet condition (visits 3 \& 6, day 19 and visits 4 \& 7, day 21), and a visit at the conclusion of the washout phase/start of the second diet condition (visit 5, day 0).
Primary Outcome
Percentage change in non-HDL-C concentration
Interventions
- OTHER corn oil
- OTHER Avocado Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2026-04-10 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT07514663 shows while recruiting
NCT07514663 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which corn oil is the first listed.
NCT07514663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07514663 about?
NCT07514663 is a clinical study titled "Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile". The goal of this clinical trial is to assess the effects of corn and avocado oils as part of controlled feeding diets on the cardiometabolic risk factor profile in men and women with mild-to-moderately elevated levels of non-high-density lipoprotein cholesterol (non-HDL-C). Participants will be aske...
What is the current status of trial NCT07514663?
This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2026-04-10. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07514663?
The interventions under investigation include: corn oil (OTHER), Avocado Oil (OTHER).
Who is sponsoring clinical trial NCT07514663?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07514663's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI